Evidence map›Paper›PMID 26049760›Full record

ReviewCurrent opinion in hematology2015

Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis.

Ulf Klein, Nicole Heise

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. HemaSphere · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Regulation of B-cell function by NF-kappaB c-Rel in health and disease.Cellular and molecular life sciences : CMLS · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ulf KleinaDepartment of Pathology & Cell Biology bDepartment of Microbiology & Immunology cHerbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA.
Nicole Heise
Columbia University Irving Medical Center · USGTx (United States) · US

Funding

The Role of NF-kB in B-Cell Differentiation and LymphomagenesisR01CA157660 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KLEIN, ULF · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA157660NCI NIH HHS R01-CA157660
6 · The paper itself

Abstract

purpose of reviewB-cell tumors originating from the transformation of germinal center B cells frequently harbor genetic mutations, leading to constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway. The present review highlights recent insights into the roles of separate NF-κB transcription factors in germinal center B-cell development and discusses implications of the results for germinal center lymphomagenesis. RECENT

findingsUnderstanding how aberrant NF-κB activation promotes tumorigenesis requires the understanding of the role of NF-κB in the tumor-precursor cells. Despite extensive knowledge on NF-κB biology, the function of this complex signaling pathway in the differentiation of germinal center B cells is largely unknown. The present review will discuss recent findings that revealed distinct roles of separate NF-κB transcription factors during the germinal center reaction in the context of germinal center lymphomagenesis. Most notably, a single NF-κB subunit, c-REL, was found to be required for the maintenance of the germinal center reaction and was associated with the activation of a metabolic program that promotes cell growth. SUMMARY: Identifying the biological roles of the separate NF-κB transcription factor subunits in germinal center biology will help to better understand the pathogenic consequences of their constitutive activation in B-cell tumors. This knowledge may be exploited for the development of targeted antitumor therapies aimed at inhibiting selectively those components of aberrant NF-κB activity which contribute to pathogenesis.

Indexed as

Gene Expression Regulation, NeoplasticB-LymphocytesCarcinogenesisCell DifferentiationGerminal CenterHumansLymphomaNeoplastic Stem CellsNF-kappa BProtein SubunitsSignal TransductionNF-kappa BProtein Subunits

Identifiers

PMID26049760
PMCPMC4459530
OpenAlexW829865463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.